Want to join the conversation?
Obesity drug developer $OREX's revenue tumbled to $10MM from $30.8MM in 3Q14. The reported revenue for the quarter includes $2.6MM in royalties earned on U.S. net sales of Contrave of $12.8MM recorded by $OREX's partner Takeda Pharmaceuticals.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.